Development and validation of the Male Post-coital Affect Scale for heterosexual men.

IF 3.8 4区医学 Q1 Medicine

Acta Neuropsychiatrica Pub Date : 2023-08-01 DOI:10.1017/neu.2023.12

Marta Pérez, Jørgen Hoppe, Anne M Landau, Michael Winterdahl

{"title":"Development and validation of the Male Post-coital Affect Scale for heterosexual men.","authors":"Marta Pérez, Jørgen Hoppe, Anne M Landau, Michael Winterdahl","doi":"10.1017/neu.2023.12","DOIUrl":null,"url":null,"abstract":"Objective: The aim of this study was to examine the reliability and validity of the Male Post-coital Affect Scale (MPAS), which was developed to assess positive post-coital feelings in men.Methods: After a pilot study, we validated our scale on a sample of American heterosexual men, who answered our questionnaire on the internet through Amazon Mechanical Turk. We tested the reliability using internal consistency. The validity was examined by assessing content, face and construct validity by testing the association between our scale, the Experience in Close Relationships Scale and other instruments.Results: A total of 484 volunteers were included in the study. Cronbach's α for the scale was 0.83. Our scale was negatively correlated with attachment avoidance, r(482) = -0.36, p < 0.001) and Perceived Stress Scale, r(482) = -0.18, p < 0.001, and positively correlated with sexual satisfaction, r(482) = 0.18, p < 0.001.Conclusion: The MPAS is a reliable and valid tool to assess positive post-coital feelings in men.","PeriodicalId":7066,"journal":{"name":"Acta Neuropsychiatrica","volume":"35 4","pages":"241-246"},"PeriodicalIF":3.8000,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Neuropsychiatrica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1017/neu.2023.12","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: The aim of this study was to examine the reliability and validity of the Male Post-coital Affect Scale (MPAS), which was developed to assess positive post-coital feelings in men.

Methods: After a pilot study, we validated our scale on a sample of American heterosexual men, who answered our questionnaire on the internet through Amazon Mechanical Turk. We tested the reliability using internal consistency. The validity was examined by assessing content, face and construct validity by testing the association between our scale, the Experience in Close Relationships Scale and other instruments.

Results: A total of 484 volunteers were included in the study. Cronbach's α for the scale was 0.83. Our scale was negatively correlated with attachment avoidance, r(482) = -0.36, p < 0.001) and Perceived Stress Scale, r(482) = -0.18, p < 0.001, and positively correlated with sexual satisfaction, r(482) = 0.18, p < 0.001.

Conclusion: The MPAS is a reliable and valid tool to assess positive post-coital feelings in men.

查看原文本刊更多论文

异性恋男性性交后情感量表的编制与验证。

目的:本研究的目的是检验男性性交后情绪量表(MPAS)的信度和效度，该量表是用来评估男性积极的性交后情绪。方法:经过初步研究，我们在美国异性恋男性样本中验证了我们的量表，他们通过亚马逊土耳其机器人在网上回答了我们的问卷。我们使用内部一致性来测试可靠性。效度是通过评估内容、面孔和结构效度来检验的，通过测试我们的量表、亲密关系体验量表和其他工具之间的关联来检验的。结果:共有484名志愿者被纳入研究。量表的Cronbach’s α为0.83。本量表与依恋回避呈负相关(r(482) = -0.36, p < 0.001)，与感知压力量表呈负相关(r(482) = -0.18, p < 0.001)，与性满意度呈正相关(r(482) = 0.18, p < 0.001)。结论:MPAS是一种可靠、有效的评估男性性交后积极感受的工具。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Acta Neuropsychiatrica 医学-精神病学

CiteScore

8.50

自引率

5.30%

发文量

审稿时长

6-12 weeks

期刊介绍： Acta Neuropsychiatrica is an international journal focussing on translational neuropsychiatry. It publishes high-quality original research papers and reviews. The Journal''s scope specifically highlights the pathway from discovery to clinical applications, healthcare and global health that can be viewed broadly as the spectrum of work that marks the pathway from discovery to global health.